Accueil・Liste d'Actions・Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals Inc

Fermé

4.26 3.15

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

4.01

Max

4.23

Chiffres clés
By Trading Economics
Revenu	-136K -35M
BPA	-0.503
Employés	106
EBITDA	2.2M -35M

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+86.75% upside

Dividendes
By Acuity
Prochains Résultats	6 nov. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	36M 331M
Ouverture précédente	1.11
Clôture précédente	4.26

Zentalis Pharmaceuticals Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

11 août 2026, 23:56 UTC

Coherent Corp shares are higher in after-market trading, continuing a strong upward trend since Tuesday's close amid broader market volatility and fluctuating oil prices.

11 août 2026, 23:56 UTC

Paychex Inc. shares are higher in after-market trading, maintaining a position above its 20-day moving average amid recent volatility in Brent crude oil prices.

11 août 2026, 23:56 UTC

Arcos Dorados Holdings shares are higher in after-market trading, despite five consecutive lower sessions. Market volatility is influenced by rising Brent crude oil prices.

11 août 2026, 23:56 UTC

Citizens Financial Group Inc shares are higher in after-hours trading, remaining above their 20-day moving average and near the upper end of their one-month range.

11 août 2026, 23:56 UTC

News

GrowGeneration reports second-quarter net sales of $43.2 million, a 5.5% increase. Shares are higher in after-market trading following the earnings announcement.

11 août 2026, 23:56 UTC

Assurant Inc. shares rose after-market, recovering from an early dip amid broader market volatility linked to Brent crude oil fluctuations and investor caution ahead of CPI data.

11 août 2026, 23:56 UTC

News

Digital Realty Trust announced a quarterly dividend of $1.22 per share. Shares are trading higher in after-market hours following the announcement.

11 août 2026, 23:56 UTC

Macy's Inc. shares are higher in after-market hours, driven by notable strength in the Broadline Retail sub-sector, despite no specific company news identified.

11 août 2026, 23:56 UTC

Monro Inc shares are trading higher in after-market hours amid broader market volatility and rising Brent crude oil prices above $90 per barrel.

11 août 2026, 23:56 UTC

Social Media

Twilio Inc shares are higher in after-market hours, supported by social media discussions on a "massive stage 1 base breakout" and increased full-year guidance.

11 août 2026, 23:56 UTC

Kaiser Aluminum Corp shares are higher in after-market trading. The stock remains above its 20-day moving average amid broader market volatility.

11 août 2026, 23:56 UTC

Alibaba Group Holding Ltd shares are higher in after-market trading, reflecting routine performance within a narrow range above the 20-day moving average.

11 août 2026, 23:56 UTC

CH Robinson Worldwide shares are trading higher in after-market hours, reflecting some resilience amid broader market volatility and fluctuating Brent crude oil prices.

11 août 2026, 23:56 UTC

Fluence Energy Inc shares are higher in after-market hours, trading within a narrow range. No specific news was identified to explain the movement.

11 août 2026, 23:56 UTC

Chemours Co shares are higher in after-market trading, reflecting notable activity since Tuesday's close. The stock remains below its 20-day moving average.

11 août 2026, 23:56 UTC

Genco Shipping & Trading Ltd shares are higher in after-market trading, rising from session lows despite being below its 20-day moving average and near a one-month low.

11 août 2026, 23:56 UTC

Broadridge Financial Solutions Inc shares are higher in after-market trading, recovering from a session dip and remaining above the 20-day moving average.

11 août 2026, 23:56 UTC

News

UBS maintains Buy rating on Rapid7 and raises price target to $12. Shares are trading higher in after-market hours, reflecting positive investor sentiment.

11 août 2026, 23:56 UTC

Kraft Heinz Co shares are trading slightly higher in after-market hours. No specific news was identified to explain this movement.

11 août 2026, 23:56 UTC

PennyMac Mortgage Investment Trust shares are higher in after-market trading, reflecting a slight uptick amid broader market volatility. No specific news was identified.

11 août 2026, 23:56 UTC

Correlated Moves

American Water Works Company reported no specific news after-market hours. The stock was roughly flat, reflecting broader market sentiment and stability.

11 août 2026, 23:56 UTC

Atmos Energy Corp shares are trading higher in after-market hours. This movement occurs amid broader market volatility and fluctuating Brent crude oil prices.

11 août 2026, 23:56 UTC

Axon Enterprise Inc. shares are lower in after-market trading, despite a recent trend of three consecutive higher daily closes.

11 août 2026, 23:52 UTC

ETF Constituents

Correlated Moves

Macro News

iShares MSCI South Korea ETF rises in after-market trading, supported by technology stock gains and broader equity market movements. It remains above its 20-day moving average.

11 août 2026, 23:52 UTC

Monster Beverage Corp. shares rose during after-market hours, recovering from a slight pullback. Market focus remains on upcoming economic data, including the CPI report.

11 août 2026, 23:52 UTC

Social Media

Entravision Communications Corp shares are rising in after-market trading amid positive investor sentiment and discussions of potential favorable price movements.

11 août 2026, 23:52 UTC

Correlated Moves

Booking Holdings Inc shares are lower in after-market hours amid broader market declines. Investors await the upcoming consumer price index report for further guidance.

11 août 2026, 23:51 UTC

Xpeng Inc. shares were roughly flat in after-market trading. Market attention remains on the upcoming consumer price index report amid recent job loss data.

11 août 2026, 23:51 UTC

Correlated Moves

Cohu Inc. shares are lower in after-market trading, influenced by a slight decline in the Nasdaq 100 Index and overall market sentiment.

11 août 2026, 23:51 UTC

Eton Pharmaceuticals Inc shares are lower in after-market trading amid unusual volatility. No specific news was identified to explain the decline.

Comparaison

Variation de prix

Zentalis Pharmaceuticals Inc prévision

Objectif de Prix

By TipRanks

86.75% hausse

Prévisions sur 12 Mois

Moyen 7.75 USD 86.75%

Haut 11 USD

Bas 4 USD

Basé sur 9 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

9 ratings

Achat

Maintien

Vente

Basé sur 9 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos Zentalis Pharmaceuticals Inc

Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its products candidatures include the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase for the treatment of inhibitor for advanced solid tumors and hematological malignancies; in Phase 2 clinical trial as a monotherapy for the treatment of uterine serous carcinoma indications; Phase 2 clinical trial in Cyclin E1 driven high-grade serous ovarian cancer, fallopian tube, or primary peritoneal cancer; Phase 1/2 clinical trial in combination with PARPi for platinum-resistant ovarian cancer; Phase 1b clinical trial in combination with chemotherapy in platinum-resistant ovarian, and peritoneal or fallopian tube cancer; Phase 1/2 clinical trial in combination with chemotherapy in relapsed or refractory osteosarcoma; Phase 1/2 clinical trial with encorafenib and cetuximab for mutant metastatic colorectal cancer; and Phase 1/2 clinical trial in combination with chemotherapy in pancreatic cancer. The company's products pipeline also includes ZN-d5, an oral small molecule inhibitor of B-cell lymphoma 2, for hematological malignancies and related disorders; and BCL-xL heterobifunctional degrader, a member of the anti-apoptotic BCL-2 proteins, for solid tumors and hematological malignancies. Zentalis Pharmaceuticals, Inc. has licensing agreements and strategic collaborations with Recurium IP Holdings, LLC; Pfizer, Inc.; Zentera Therapeutics; Dana-Farber; and GlaxoSmithKline plc. The company was incorporated in 2014 and is headquartered in New York, New York.